Document Detail

RNA-Seq for Enrichment and Analysis of IRF5 Transcript Expression in SLE.
MedLine Citation:
PMID:  23349905     Owner:  NLM     Status:  In-Data-Review    
Polymorphisms in the interferon regulatory factor 5 (IRF5) gene have been consistently replicated and shown to confer risk for or protection from the development of systemic lupus erythematosus (SLE). IRF5 expression is significantly upregulated in SLE patients and upregulation associates with IRF5-SLE risk haplotypes. IRF5 alternative splicing has also been shown to be elevated in SLE patients. Given that human IRF5 exists as multiple alternatively spliced transcripts with distinct function(s), it is important to determine whether the IRF5 transcript profile expressed in healthy donor immune cells is different from that expressed in SLE patients. Moreover, it is not currently known whether an IRF5-SLE risk haplotype defines the profile of IRF5 transcripts expressed. Using standard molecular cloning techniques, we identified and isolated 14 new differentially spliced IRF5 transcript variants from purified monocytes of healthy donors and SLE patients to generate an IRF5 variant transcriptome. Next-generation sequencing was then used to perform in-depth and quantitative analysis of full-length IRF5 transcript expression in primary immune cells of SLE patients and healthy donors by next-generation sequencing. Evidence for additional alternatively spliced transcripts was obtained from de novo junction discovery. Data from these studies support the overall complexity of IRF5 alternative splicing in SLE. Results from next-generation sequencing correlated with cloning and gave similar abundance rankings in SLE patients thus supporting the use of this new technology for in-depth single gene transcript profiling. Results from this study provide the first proof that 1) SLE patients express an IRF5 transcript signature that is distinct from healthy donors, 2) an IRF5-SLE risk haplotype defines the top four most abundant IRF5 transcripts expressed in SLE patients, and 3) an IRF5 transcript signature enables clustering of SLE patients with the H2 risk haplotype.
Rivka C Stone; Peicheng Du; Di Feng; Kopal Dhawan; Lars Rönnblom; Maija-Leena Eloranta; Robert Donnelly; Betsy J Barnes
Related Documents :
20421205 - Yeast targets for mrna methylation.
9846995 - Altered cytokine (receptor) mrna expression as a tool in immunotoxicology.
24755105 - Activation of mtor contributes to foam cell formation in the radial arteries of patient...
18952865 - Sandwich hybridization assay for sensitive detection of dynamic changes in mrna transcr...
22766795 - Expression of mirnas and pten in endometrial specimens ranging from histologically norm...
18209065 - An essential role of sialylated o-linked sugar chains in the recognition of mouse cd99 ...
Publication Detail:
Type:  Journal Article     Date:  2013-01-18
Journal Detail:
Title:  PloS one     Volume:  8     ISSN:  1932-6203     ISO Abbreviation:  PLoS ONE     Publication Date:  2013  
Date Detail:
Created Date:  2013-01-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101285081     Medline TA:  PLoS One     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e54487     Citation Subset:  IM    
Department of Biochemistry & Molecular Biology, New Jersey Medical School, UMDNJ, Newark, New Jersey, United States of America ; New Jersey Medical School-University Hospital Cancer Center, UMDNJ, Newark, New Jersey, United States of America.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Naturally occurring mutations in large surface genes related to occult infection of hepatitis B viru...
Next Document:  Th Inducing POZ-Kruppel Factor (ThPOK) Is a Key Regulator of the Immune Response since the Early Ste...